With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.17217-57-1,4,4′-Dimethoxy-2,2′-bipyridine,as a common compound, the synthetic route is as follows.
General procedure: The synthesis of complexes was carried out by single potsynthesis. An anhydrous methanolic solution (10 mL) of 4-fluoro-N-salicylideneaniline (0.6456, 3 mmol) was addeddropwise to a vigorously stirred solution of 2,2?-bipyridine(0.1561, 1 mmol) in 10 mL methanol. To this solution ofligands, a methanolic solution of EuCl3 (0.2583 g, 1 mmol)was added slowly with continuous stirring. The pH of thereaction mixture obtained was adjusted to 6.0?7.0. Afteradjusting the pH, the reaction mixture was refluxed at 60 ¡ãC.The refluxing was continued for 5 h. The light yellow solutionso obtained was evaporated at room temperature to give thesolid compound which was extracted with diethyl ether. Thecompound obtained after extraction is C1 (Scheme 1).
17217-57-1, 17217-57-1 4,4′-Dimethoxy-2,2′-bipyridine 2733927, acatalyst-ligand compound, is more and more widely used in various fields.
Reference£º
Article; Sengar, Manju; Narula, Anudeep Kumar; Journal of Fluorescence; vol. 29; 1; (2019); p. 111 – 120;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI